Clywedog Therapeutics, Inc. (NasdaqCM: CLYD)
Health Care · Biotechnology · US
—
— today · — 1Y
Public summary
A free snapshot of Clywedog Therapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Clywedog Therapeutics, Inc. (NasdaqCM: CLYD) operates in the Biotechnology industry within the Health Care sector.
Tweenvest scores Clywedog Therapeutics, Inc. across four factors: quality 38/100. Its strongest factor is quality.
CLYD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -11.25
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- —
- 52-week low
- —
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rebus Holdings, Inc.OTCPK: RBSH | $32.00 | $0.00 | -99.00% |
| HAVN Life Sciences Inc.OTCPK: HAVL.F | $29.00 | $0.00 | 0.00% |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $24.00 | $0.00 | -99.00% |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | -99.00% |
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $0.00 | 0.00% |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | 0.00% |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $0.00 | 0.00% |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $0.00 | 0.00% |